MOMENTA PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Collaboration revenue
Product revenue
Research and development revenue
Total collaboration revenue
Operating expenses:
Research and development
General and administrative
Other operating expense
Restructuring
Total operating expenses
Operating loss
Other income (expense):
Interest income
Interest expense
Other income (expense), net
Total other income, net
Net loss
Net unrealized holding gain (loss) on available-for-sale debt securities
Comprehensive loss
Net loss per share:
Basic and diluted (in dollars per share)
Weighted average shares outstanding:
Basic and diluted (in shares)

Comments